Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2020	Sep. 30, 2019
Investments	$ 47,700,000	$ 51,100,000
Current Assets
Cash and cash equivalents	290,500,000	214,100,000
Restricted Cash, Current	0	419,700,000
Trade accounts receivable, net of allowances of $20.8 and $20.6 as of March 31, 2020 and September 30, 2019	655,400,000	653,300,000
Inventories, net of reserves	265,500,000	269,600,000
Other current assets	130,300,000	106,700,000
Total current assets	1,341,700,000	1,663,400,000
Property, plant and equipment	841,200,000	829,600,000
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	546,800,000	532,800,000
Property, Plant and Equipment, Net	294,400,000	296,800,000
Goodwill	1,805,700,000	1,800,900,000
Other intangible assets and software, net	1,006,500,000	1,033,500,000
Deferred Income Tax Assets, Net	32,600,000	33,100,000
Other assets	166,200,000	91,300,000
Assets	4,647,100,000	4,919,000,000.0
Current Liabilities
Trade accounts payable	224,700,000	197,600,000
Short-term borrowings	245,600,000	660,400,000
Accrued compensation	98,500,000	130,400,000
Accrued product warranties	29,000,000.0	29,700,000
Accrued rebates	47,500,000	47,700,000
Deferred Revenue	105,700,000	107,300,000
Other current liabilities	134,400,000	95,200,000
Total current liabilities	885,400,000	1,268,300,000
Long-term debt	1,864,400,000	1,783,100,000
Accrued pension and postretirement benefits	100,800,000	80,800,000
Deferred Income Tax Liabilities, Net	123,700,000	143,000,000.0
Other long-term liabilities	123,900,000	70,500,000
Total Liabilities	3,098,200,000	3,345,700,000
Commitments and Contingencies (Note 14)
SHAREHOLDERS' EQUITY
Common Stock, Value, Issued	4,400,000	4,400,000
Additional paid-in capital	644,400,000	637,400,000
Retained earnings	2,025,200,000	1,967,400,000
Accumulated other comprehensive loss	(223,600,000)	(182,500,000)
Treasury stock, common shares at cost: 21,929,904 as of March 31, 2020 and 21,832,623 as of September 30, 2019	(901,500,000)	(853,400,000)
Total Shareholders’ Equity	1,548,900,000	1,573,300,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,548,900,000	1,573,300,000
Total Liabilities and Shareholders' Equity	4,647,100,000	4,919,000,000.0
Allowance for possible losses and discounts on trade receivables	$ 20.8	$ 20.6
Shares authorized	1,000,000
Common Stock, Shares Authorized	199,000,000
Common Stock, Shares, Issued	88,457,634
Common Stock, Shares, Outstanding	66,527,730	66,625,011
Treasury Stock, Common, Shares	21,929,904	21,832,623